Verified peer comparison
InMed Pharmaceuticals vs Royalty Management Holding Financial Comparison
Direct answer
InMed Pharmaceuticals and Royalty Management Holding are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free InMed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- InMed Pharmaceuticals Revenue
- 4,942,633 USD
- Royalty Management Holding Revenue
- 4,949,916 USD
- InMed Pharmaceuticals Operating income
- -7,917,995 USD
- Royalty Management Holding Operating income
- -293,617 USD